DaVita Inc. logo

DaVita Inc. (TRL)

Market Open
23 Feb, 20:00
XHAN XHAN
128. 35
+1.65
+1.3%
- Market Cap
16.41 P/E Ratio
- Div Yield
0 Volume
7.83 Eps
126.7
Previous Close
Day Range
125.95 128.35
Year Range
86.8 141.5
Want to track TRL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DVA earnings report is expected in 76 days (11 May 2026)

Summary

TRL trading today higher at €128.35, an increase of 1.3% from yesterday's close, completing a monthly increase of 33.34% or €32.09. Over the past 12 months, TRL stock gained 33.34%.
TRL is not paying dividends to its shareholders.
The last earnings report, released on Feb 18, 2026, exceeded the consensus estimates by 0.3%. On average, the company has fell short of earnings expectations by -2.06%, based on the last three reports. The next scheduled earnings report is due on May 11, 2026.
DaVita Inc. has completed 3 stock splits, with the recent split occurring on Sep 09, 2013.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NYSE (USD).

TRL Chart

Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 hours ago
Is DaVita (DVA) Stock Undervalued Right Now?

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 day ago
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 days ago

DaVita Inc. (TRL) FAQ

What is the stock price today?

The current price is €128.35.

On which exchange is it traded?

DaVita Inc. is listed on XHAN.

What is its stock symbol?

The ticker symbol is TRL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 2.41.

When is the next earnings date?

The next earnings report will release on May 11, 2026.

Has DaVita Inc. ever had a stock split?

DaVita Inc. had 3 splits and the recent split was on Sep 09, 2013.

DaVita Inc. Profile

Health Care Providers & Services Industry
Healthcare Sector
Mr. Javier J. Rodriguez CEO
XHAN Exchange
US23918K1088 ISIN
United States Country
78,000 Employees
- Last Dividend
9 Sep 2013 Last Split
31 Oct 1995 IPO Date

Overview

DaVita Inc. is a leading healthcare provider specializing in kidney dialysis services for patients grappling with chronic kidney failure across the United States. Initially known as DaVita HealthCare Partners Inc., the company underwent a rebranding to DaVita Inc. in September 2016. Since its establishment in 1994, DaVita has been committed to delivering exceptional care and support to patients with end-stage renal disease (ESRD). With its headquarters located in Denver, Colorado, DaVita operates an extensive network of kidney dialysis centers, complemented by various outpatient and inpatient services designed to cater to the comprehensive needs of individuals undergoing dialysis treatment.

Products and Services

  • Outpatient Hemodialysis Services:

    DaVita provides essential dialysis treatment in its outpatient centers, ensuring patients receive the necessary care without the need for hospital admission. These services cater to the routine management of kidney failure.

  • Hospital Inpatient Hemodialysis Services:

    For patients who are hospitalized and cannot visit an outpatient center, DaVita offers in-hospital hemodialysis. This ensures continuity of care even during acute medical conditions.

  • Home-Based Hemodialysis Services:

    Understanding the need for comfort and convenience, DaVita supports home-based dialysis treatments. This option empowers patients to manage their condition in the familiar surroundings of their homes.

  • Clinical Laboratory Services:

    Operational clinical laboratories provide routine and physician-prescribed laboratory tests specifically designed for ESRD patients, ensuring comprehensive monitoring and management of their condition.

  • Management and Administrative Services:

    DaVita offers extensive management and administrative support to outpatient dialysis centers, encompassing both company-operated and partnered facilities to ensure they operate efficiently and deliver high-quality care.

  • Integrated Care and Disease Management:

    In certain risk-based and integrated care arrangements, DaVita extends beyond dialysis by providing coordinated care and disease management services to address the overall health needs of their patients.

  • Clinical Research Programs:

    Dedicated to advancing knowledge and treatments for kidney disease, DaVita participates in and leads clinical research studies, contributing to the development of innovative care practices.

  • Physician Services:

    A comprehensive network of physicians working with DaVita ensures expert medical care and consultation for patients, aiding in the efficient management of kidney disease.

  • Comprehensive Kidney Care Services:

    Through a holistic approach, DaVita offers extensive kidney care services, including patient education, nutritional counseling, and support groups, to aid in the overall wellbeing of individuals with kidney disease.

  • Acute Inpatient Dialysis Services:

    For patients who require more intensive dialysis treatment while hospitalized, DaVita provides acute inpatient dialysis services, ensuring critical care needs are met.

  • Transplant Software Business:

    DaVita also engages in the development and maintenance of transplant software, facilitating the management and tracking of kidney transplant processes and patient data.

Contact Information

Address: 2000 16th Street
Phone: 720 631 2100